Onkologie. 2009:3(1):28-31

Radiotherapy of the breast cancer

Martina Kubecová
Radioterapeutická a onkologická klinika 3. LF UK a FNKV, Praha

Radiotherapy belongs to basic treatment modalities of breast cancer. As radical treatment methods is used mainly as postoperative



method: In this case it decreases locoregional reccurences and has effect upon survival. As palliate method it suppresses pains, stops

bleeding and pathological fractures. Radiotherapy is the most often combined with other treatment modalities.

Keywords: breast cancer, radiotherapy.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kubecová M. Radiotherapy of the breast cancer. Onkologie. 2009;3(1):28-31.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Overgard M, Hansen PS, Overgard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949. Go to original source... Go to PubMed...
    2. Van de Steene J, Soete G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol 2000; 55: 263. Go to original source... Go to PubMed...
    3. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A metaanalysis. J Clin. Onol 2000; 18: 1220. Go to original source... Go to PubMed...
    4. Recht A, Edge SB, Solin IJ, et al. Postmastectomy radiotherapy clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1539. Go to original source... Go to PubMed...
    5. Fisher B, Anderson S, Bryant J, et al. Twenty-year folow-up a ranomized trial comparing tptal mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233. Go to original source... Go to PubMed...
    6. Šlampa P, et al. Radiační onkologie v praxi; Masarykův onkol. Ústav, Brno, 2004: 87-91.
    7. Timothy J, Whelan BM, Do-Hoon K, et al. Clinical experience Using Hypofractionated Radiation Schedules in Breast Cancer. Seminar in Rad Oncol 2008; 18: 257-264. Go to original source... Go to PubMed...
    8. Romestaiging P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997; 15: 963. Go to original source... Go to PubMed...
    9. Bartelinek H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breats cancer with standard radiotherapy with or without additional radiation.N Engl J Med 2001; 345: 1378. Go to original source... Go to PubMed...
    10. Taylor CW, Povall JM, McGale P, et al. Cardiac dose from tngential breast cancer radiotherapy in the year 2006. Int J Rad Onc Biol Phys 2008; 72(2): 501-507. Go to original source... Go to PubMed...
    11. Correa CR, Das IJ, Litt HI, et al. Association between tangential beam treatment parameters and cardiac abnormalities after definitive radiation treatment for left-sided breast cancer. Int J Rad Onc Biol Phys 2008; 72(2): 508-516. Go to original source... Go to PubMed...
    12. Dolečková M, Šlampa P, Králová D. Karcinomy prsu. In: Šlampa P, Petera J, a kol. Radiační onkologie, Praha: Galén 2007; 215-225.
    13. Vaiday JS, Baum M, Tobias JS, et al. The novel technique of delivering targeted intraoperative radiotherapy for early breast cancer. Eur J Surg Oncol 2002; 28: 447. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.